---
figid: PMC6726851__Dtsch_Arztebl_Int-116_0497_002
figlink: /pmc/articles/PMC6726851/figure/F2/
number: F2
caption: Inhibition of the MAPK(RAS-RAF-MEK-ERK) signaling pathway by BRAF inhibitors
  and MEK inhibitorsMAPK, mitogen-activated protein kinase; RTK, receptor-tyrosine-kinase
pmcid: PMC6726851
papertitle: The Systemic Treatment of Melanoma.
reftext: Patrick Terheyden, et al. Dtsch Arztebl Int. 2019 Jul;116(29-30):497-504.
pmc_ranked_result_index: '62413'
pathway_score: 0.8612274
filename: Dtsch_Arztebl_Int-116_0497_002.jpg
figtitle: Inhibition of the MAPK(RAS-RAF-MEK-ERK) signaling pathway by BRAF inhibitors
  and MEK inhibitorsMAPK, mitogen-activated protein kinase; RTK, receptor-tyrosine-kinase
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6726851__Dtsch_Arztebl_Int-116_0497_002.html
  '@type': Dataset
  description: Inhibition of the MAPK(RAS-RAF-MEK-ERK) signaling pathway by BRAF inhibitors
    and MEK inhibitorsMAPK, mitogen-activated protein kinase; RTK, receptor-tyrosine-kinase
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRAS
  - MAP2K2
  - MAPK1
  - MAPK3
  - KRAS
  - NRAS
  - MAP2K1
  - Vemurafenib
  - Dabrafenib
  - Encorafenib
  - Cobimetinib
  - Trametinib
  - Binimetinib
  - Melanoma
genes:
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
chemicals:
- word: Vemurafenib
  source: MESH
  identifier: C551177
- word: Dabrafenib
  source: MESH
  identifier: C561627
- word: Encorafenib
  source: ''
  identifier: ''
- word: Cobimetinib
  source: MESH
  identifier: C574276
- word: Trametinib
  source: MESH
  identifier: C560077
- word: Binimetinib
  source: MESH
  identifier: C581313
diseases:
- word: Melanoma
  source: MESH
  identifier: D008545
figid_alias: PMC6726851__F2
redirect_from: /figures/PMC6726851__F2
figtype: Figure
---
